Insiders · KPRX

KPRX insider transactions

Kiora Pharmaceuticals Inc. (KPRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for KPRX

• 66d
  SEC Form 4 filed by Tosca Melissa

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 66d
  SEC Form 4 filed by Daniels Eric Joseph

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 66d
  SEC Form 4 filed by Strem Brian M.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 89d
  SEC Form 4 filed by Kiora Pharmaceuticals Inc.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 89d
  SEC Form 4 filed by Kiora Pharmaceuticals Inc.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 89d
  President and CEO Strem Brian M. was granted 16,733 shares, increasing direct ownership by 36% to 62,598 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 94d
  Chief Development Officer Daniels Eric Joseph covered exercise/tax liability with 238 shares, decreasing direct ownership by 0.90% to 26,137 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 94d
  President and CEO Strem Brian M. covered exercise/tax liability with 238 shares, decreasing direct ownership by 0.52% to 45,865 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  CFO Tosca Melissa was granted 7,772 shares, increasing direct ownership by 57% to 21,371 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  Chief Development Officer Daniels Eric Joseph was granted 7,772 shares, increasing direct ownership by 42% to 26,375 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  President and CEO Strem Brian M. was granted 15,941 shares, increasing direct ownership by 53% to 46,103 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  SEC Form 4 filed by Director Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  SEC Form 4 filed by Director Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  SEC Form 4 filed by Director Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  SEC Form 4 filed by Director Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  SEC Form 4 filed by Director Stengone Carmine N.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 431d
  SEC Form 4 filed by Director Walters-Hoffert Lisa

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 634d
  Director Stengone Carmine N. bought $4,600 worth of shares (1,250 units at $3.68) (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 635d
  Director Shapiro Aron bought $10,800 worth of shares (3,000 units at $3.60) (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 657d
  Director Walters-Hoffert Lisa bought $4,825 worth of shares (1,250 units at $3.86) (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 657d
  Director Tyle Praveen bought $19,800 worth of shares (5,000 units at $3.96), increasing direct ownership by 35,714% to 5,014 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 661d
  CFO Tosca Melissa bought $6,420 worth of shares (2,000 units at $3.21), increasing direct ownership by 17% to 13,599 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  President and CEO Strem Brian M. was granted 15,629 shares, increasing direct ownership by 108% to 30,160 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  CFO Tosca Melissa was granted 7,620 shares, increasing direct ownership by 192% to 11,599 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 3 filed by new insider Walters-Hoffert Lisa

  3 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  Chief Development Officer Daniels Eric Joseph was granted 7,355 shares, increasing direct ownership by 66% to 18,577 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 4 filed by Director Stengone Carmine N.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 4 filed by Director Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 4 filed by Director Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 4 filed by Director Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 4 filed by Director Walters-Hoffert Lisa

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 705d
  SEC Form 4 filed by Director Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 723d
  EVP Finance Tosca Melissa bought $525 worth of shares (100 units at $5.25), increasing direct ownership by 3% to 3,979 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 723d
  Chief Development Officer Daniels Eric Joseph bought $7,570 worth of shares (1,431 units at $5.29), increasing direct ownership by 15% to 11,222 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 724d
  Director Parsons Erin bought $25,669 worth of shares (5,260 units at $4.88) (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 724d
  President and CEO Strem Brian M. bought $14,997 worth of shares (3,000 units at $5.00), increasing direct ownership by 26% to 14,531 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  Tosca Melissa was granted 30,000 shares, increasing direct ownership by 612% to 34,900 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  Daniels Eric Joseph was granted 62,500 shares, increasing direct ownership by 242% to 88,338 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  Strem Brian M. was granted 75,000 shares, increasing direct ownership by 261% to 103,783 units (SEC Form 4)

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  SEC Form 4 filed by Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  SEC Form 4 filed by Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  SEC Form 4 filed by Stengone Carmine N.

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  SEC Form 4 filed by Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  SEC Form 4 filed by Gayron Kenneth L

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 978d
  SEC Form 4 filed by Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1032d
  SEC Form 3 filed by new insider Stengone Carmine N.

  3 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4 filed by Parsons Erin

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4: Tosca Melissa was granted 2,400 shares, increasing direct ownership by 48% to 7,400 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4: Strem Brian M. was granted 15,600 shares, increasing direct ownership by 118% to 28,783 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4: Daniels Eric Joseph was granted 15,600 shares, increasing direct ownership by 152% to 25,838 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4 filed by Gayron Kenneth L

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4 filed by Shapiro Aron

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4 filed by Tyle Praveen

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4 filed by Hollander David

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1188d
  SEC Form 4 filed by Chaney Paul G

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1321d
  SEC Form 4: Daniels Eric Joseph was granted 10,000 shares, increasing direct ownership by 4,202% to 10,238 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1321d
  SEC Form 4: Tosca Melissa was granted 2,500 shares

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1321d
  SEC Form 4: Strem Brian M. was granted 12,500 shares, increasing direct ownership by 1,830% to 13,183 units

  4 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1354d
  SEC Form 3 filed by new insider Tosca Melissa

  3 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)
• 1497d
  SEC Form 3 filed by new insider Drexler Susan L.

  3 - KIORA PHARMACEUTICALS INC (0001372514) (Issuer)